Pacifi NIPT is a prenatal screening option to detect fetal chromosomal abnormalities more accurately than conventional biochemical testing and is available to all pregnant women.
KARYO performs the control with the certification of illumina, being the first NIPT system installation in Greece.
NGS Panels
The private diagnostic laboratory KARYO provides advanced technology analyzes of genetic material to health professionals, since its establishment in 2008.
Who we are
The aim of the laboratory is the continuous development and provision of new diagnostic services based on its well-trained staff
Why to choose us
Accredited by ESYD clinical laboratory with long-term participation in international quality control programs and state-of-the-art equipment
Visit us
Find out about the communication methods and the location that serves you
Do you need clarification for your genetic tests?
Printed Information Material
Select to download the form you are interested in
Technological Equipment
The effort is continuous to have the most modern technological equipment in our laboratories.
Recent news
Find out about developments in Cytogenetics and Molecular Genetics as well as our new diagnostic tests
NSRF Upgrade for the New Markets
Upgrading micro & small businesses to develop their capabilities in new markets
NSRF Competitiveness Toolkit
Competitiveness Toolkit for Small and Very Small Businesses
Scientific publication on SARS-CoV-2 virus detection methods by the KARYO team
On December 2019, a new coronavirus disease (COVID-19) emerged in China and spread worldwide, causing acute severe respiratory syndrome. Due to the increased transmission rate of the virus, it became of great importance the early diagnosis of the disease. The coronavirus pandemic led to the development of numerous tests in order to mass screening population for active viral load and for the identification of antibodies for epidemiological purposes. This review summarizes the different diagnostic tests available to the clinicians for the diagnosis and follow up of the SARS COV-2 infections.